Venus NOVA is the first product clearance from the Company’s new R&D strategyTORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global leader in ...
New York, United States, November 14th, 2025, FinanceWireRelay, the multichain payments and liquidity network, announces the ...
Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...
The main market opportunities lie in integrating generative AI and AI agents with cloud services, enhancing hybrid/multi-cloud management, and fostering robust developer ecosystems. Vendors focusing ...
Fred Alger Management, an investment management company, released its “Alger Spectra Fund” third-quarter 2025 investor letter ...
Four new patent applications filed that aim to expand the Curadigm Nanoprimer platform intellectual property portfolio and support an initial ...
Optimer binders against three therapeutic targets to support drug validation and potential clinical trial applications ...
This article is published in Aviation Week MRO part of Aviation Week Intelligence Network (AWIN), and is complimentary ...
The company this week detailed its "ai_parse_document" technology, now integrated with Databricks' Agent Bricks platform. The ...
News-Medical.Net on MSN
Top-five pharmaceutical company expands partnership with Aptamer for multi-target Optimer® development program
Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, today announced a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback